Adams D, Kaliss N, Missner A, Valentine MM (2021) The interplay of nicotine and social stress mediate dopaminergic neuron firing in the ventral tegmental area-nucleus accumbens pathway, contributing to stress and depressive mood disorders. Georgetown Sci Res J 1(1):70–83
Ahmed SH, Badiani A, Miczek KA, Müller CP (2020) Non-pharmacological factors that determine drug use and addiction. Neurosci Biobehav Rev 110:3–27
Akbari M, Hasani J, Seydavi M (2020) Negative affect among daily smokers: A systematic review and meta-analysis. J Affect Disord 274:553–567
Al’Absi M (2006) Hypothalamic–pituitary–adrenocortical responses to psychological stress and risk for smoking relapse. Int J Psychophysiol 59(3):218–227
Albrechet-Souza L et al (2015) Corticotropin releasing factor binding protein and CRF 2 receptors in the ventral tegmental area: modulation of ethanol binge drinking in C 57 BL/6J mice. Alcohol: Clin Exp Res 39(9):1609–1618
Ansell EB, Gu P, Tuit K, Sinha R (2012) Effects of cumulative stress and impulsivity on smoking status. Hum Psychopharmacol Clin Exp 27:200–208
Avelar AJ, George O (2022) How nicotine withdrawal symptoms fight each other: interpeduncular GABA neuron activity dynamically controls negative affect vs. coping behavior. Neuropsychopharmacology 47:617–618
Baker TE, Zeighami Y, Dagher A, Holroyd CB (2020) Smoking decisions: altered reinforcement learning signals induced by nicotine state. Nicotine Tob Res 22:164–171
Barrington-Trimis JL et al (2016) The e-cigarette social environment, e-cigarette use, and susceptibility to cigarette smoking. J Adolesc Health 59:75–80
PubMed PubMed Central Google Scholar
Benowitz NL (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319:1318–1330
Benowitz NL (1996) Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 36:597–613
Berlin GS, Hollander E (2014) Compulsivity, impulsivity, and the DSM-5 process. CNS Spectr 19:62–68
Biała G, Budzyńska B, Kruk M (2005) Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol Rep 57:755–760
Bruijnzeel AW, Markou A (2004) Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats. Neuropharmacology 47:572–579
Bruijnzeel AW, Zislis G, Wilson C, Gold MS (2007) Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32:955–963
Bruijnzeel AW, Prado M, Isaac S (2009) Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiat 66:110–117
Brunzell DH, Stafford AM, Dixon CI (2015) Nicotinic receptor contributions to smoking: insights from human studies and animal models. Curr Addict Rep 2:33–46
PubMed PubMed Central Google Scholar
Burke AR, DeBold JF, Miczek KA (2016) CRF type 1 receptor antagonism in ventral tegmental area of adolescent rats during social defeat: prevention of escalated cocaine self-administration in adulthood and behavioral adaptations during adolescence. Psychopharmacology 233:2727–2736
CAS PubMed PubMed Central Google Scholar
Butler K, Forget B, Heishman SJ, Le Foll B (2021) Significant association of nicotine reinforcement and cue reactivity: a translational study in humans and rats. Behav Pharmacol 32:212–219
PubMed PubMed Central Google Scholar
Caggiula AR et al (1998) The role of corticosteroids in nicotine’s physiological and behavioral effects. Psychoneuroendocrinology 23:143–159
Carrette LLG et al (2023) Hyperconnectivity of two separate long-range cholinergic systems contributes to the reorganization of the brain functional connectivity during nicotine withdrawal in male mice. eNeuro10:ENEURO.0019–23.2023. https://doi.org/10.1101/2023.03.29.534836
Casarrubea M et al (2015) Acute nicotine induces anxiety and disrupts temporal pattern organization of rat exploratory behavior in hole-board: a potential role for the lateral habenula. Front Cell Neurosci 9:197
PubMed PubMed Central Google Scholar
CDCTobaccoFree (2021) Fast facts. Centers for disease control and prevention. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm. Accessed 15 June 2025
Changeux J-P (2010) Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci 11:389–401
Changeux JP et al (1998) Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res Rev 26(2–3):198–216
Chellian R et al (2021) Rodent models for nicotine withdrawal. J Psychopharmacol 35:1169–1187
CAS PubMed PubMed Central Google Scholar
Clarke PBS, Hommer DW, Pert A, Skirboll LR (1987) Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: neuroanatomical and electrophysiological evidence. Neuroscience 23:1011–1019
Cohen A, George O (2013) Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. Front Psychiatr 4:41
Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P (2002) SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451–463
Cohen A, Koob GF, George O (2012) Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology 37:2153–2160
CAS PubMed PubMed Central Google Scholar
Cohen A et al (2015) Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats. Addict Biol 20:56–68
Cohen G, Bellanca CM, Bernardini R, Rose JE, Polosa R (2024) Personalized and adaptive interventions for smoking cessation: Emerging trends and determinants of efficacy. iScience 27:111090
PubMed PubMed Central Google Scholar
Corrigall WA (1992) A rodent model for nicotine self-administration. In: Boulton AA, Baker GB, Wu PH (eds) Animal models of drug addiction. Humana Press, Totowa, NJ, pp. 315–344. https://doi.org/10.1385/0-89603-217-5:315
Cottone P et al (2009) CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci 106(47):20016–20020. https://doi.org/10.1073/pnas.0908789106
PubMed PubMed Central Google Scholar
Covington HE, Miczek KA (2001) Repeated social-defeat stress, cocaine or morphine. Psychopharmacology 158:388–398
Covington HE et al (2005) Brief social defeat stress: long lasting effects on cocaine taking during a binge and Zif268 mRNA expression in the amygdala and prefrontal cortex. Neuropsychopharmacol 30:310–321
Current Cigarette Smoking Among Adults — United States (2005–2012). https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6302a2.htm. Accessed 15 June 2025
Damaj MI, Kao W, Martin BR (2003) Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther 307:526–534
De Fonseca FR, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M (1996) Corticotropin-releasing factor (CRF) antagonist [D-Phe12, Nle 21, 38, C alpha MeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 276(1):56–64
de Jong IE, de Kloet ER (2004) Glucocorticoids and vulnerability to psychostimulant drugs: toward substrate and mechanism. Ann N Y Acad Sci 1018(1):192–198
Diagnostic and Statistical Manual of Mental Disorders (n.d.) DSM library. https://doi.org/10.1176/appi.books.9780890425787
Domingues LP, Antonio BDB, Oliveira MGMD, Quadros IMHD (2019) Consequence of two protocols of social defeat stress on nicotine-induced psychomotor effects in mice. BioMed Res Int 2019(1):5404251
PubMed PubMed Central Google Scholar
Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology 122:390–394
Donny EC et al (1998) Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology 136:83–90
Comments (0)